BridgeMD
New treatment option for Open-angle Glaucoma
Official title Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients
ClinicalTrials.gov ID: NCT06885827
What this study is testing
- What it's testing
- This study aims to determine whether a combination of vitamins (B6, B9, B12, and choline) can help protect the eyes of people with glaucoma and slow vision loss. The study will assess whether these vitamins support retinal cells and maintain or improve their function.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligibility Criteria Patients with the following characteristics will be eligible for inclusion in the trial:
- 18 years or older at the time of inclusion
- Diagnosis of Primary Open-Angle Glaucoma (POAG), Normal Tension-Glaucoma (NTG) or Pseudoexfoliation Glaucoma (PEXG) in one or both eyes diagnosticed...
- Best corrected Snellen VA of 0.3 or better in the study eye(s)
- Two or more reliable VF tests with less than 15% false positives
You likely can't join if
- Patients who meet any of the following criteria will be excluded from participation in the study:
- Visual field damage worse than -16dB in the study eye(s)
- Eye pressure greater than 35 mmHg in study eye(s) on either of two measurement occasions or a mean pressure of 30 mmHg over two occasions
- Any disease affecting retinal function
- Neurological or other non-glaucomatous conditions that may affect the visual field
- Inability to perform visual field examination
See the full eligibility criteria
- Eligibility Criteria Patients with the following characteristics will be eligible for inclusion in the trial:
- 18 years or older at the time of inclusion
- Diagnosis of Primary Open-Angle Glaucoma (POAG), Normal Tension-Glaucoma (NTG) or Pseudoexfoliation Glaucoma (PEXG) in one or both eyes diagnosticed by an ophthalmologist.
- Best corrected Snellen VA of 0.3 or better in the study eye(s)
- Two or more reliable VF tests with less than 15% false positives
- Patients who meet any of the following criteria will be excluded from participation in the study:
- Visual field damage worse than -16dB in the study eye(s)
- Eye pressure greater than 35 mmHg in study eye(s) on either of two measurement occasions or a mean pressure of 30 mmHg over two occasions
- Any disease affecting retinal function
- Neurological or other non-glaucomatous conditions that may affect the visual field
- Inability to perform visual field examination
- Unwillingness to stop any intake of multivitamins or B vitamin substances
- Known allergy or intolerance to B-vitamins
- Previous eye surgery, except for uncomplicated cataract surgery
- Pregnant or breastfeeding women
- Women of childbearing potential who do not use reliable contraception
- Any disease or condition likely to prevent long-term follow-up
- Cancer diagnosis within the last 5 years (except treated squamous cell carcinoma)
- History of liver disease or stomach ulcers
- Inability to understand and speak Swedish or English
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Stockholm County, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Stockholm County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.